KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) FCF Payout Ratio (2019 - 2025)

Historic FCF Payout Ratio for Royalty Pharma (RPRX) over the last 7 years, with Q4 2025 value amounting to 0.44.

  • Royalty Pharma's FCF Payout Ratio rose 24125.79% to 0.44 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.21, marking a year-over-year decrease of 5552.28%. This contributed to the annual value of 0.21 for FY2025, which is 5552.28% down from last year.
  • Royalty Pharma's FCF Payout Ratio amounted to 0.44 in Q4 2025, which was up 24125.79% from 0.13 recorded in Q3 2025.
  • Over the past 5 years, Royalty Pharma's FCF Payout Ratio peaked at 5.46 during Q1 2021, and registered a low of 0.72 during Q4 2021.
  • Over the past 5 years, Royalty Pharma's median FCF Payout Ratio value was 0.08 (recorded in 2022), while the average stood at 0.28.
  • In the last 5 years, Royalty Pharma's FCF Payout Ratio surged by 115768.27% in 2021 and then tumbled by 88120.14% in 2024.
  • Quarter analysis of 5 years shows Royalty Pharma's FCF Payout Ratio stood at 0.72 in 2021, then surged by 114.34% to 0.1 in 2022, then plummeted by 202.85% to 0.11 in 2023, then surged by 219.81% to 0.13 in 2024, then surged by 241.26% to 0.44 in 2025.
  • Its FCF Payout Ratio stands at 0.44 for Q4 2025, versus 0.13 for Q3 2025 and 0.11 for Q2 2025.